Klarity-C Drops
Subpotent Drug
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Lack of Process Controls
Cause type: cGMP deviation
Departures from current Good Manufacturing Practice found in production or during FDA inspection. A broad quality-system cause: the batch was made under conditions that fall short of FDA manufacturing standards. All cgmp deviation recalls.
Cyclosporine 1% Human Eye Drops, Westlab Pharmacy, Inc., Gainesville, FL 32607 NDC 10002-2776-92
Compare with the code on your package — it is the most precise check available.
Drug: Cyclosporine Category: Eye Drops & Ophthalmic
Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.
Subpotent Drug
Lack of Assurance of Sterility
Crystallization: bottles of Sandimmune Oral Solution were determined to contain crystals
Crystallization: bottles of Sandimmune Oral Solution were determined to contain crystals.
Subpotent: Out of Specification result observed for low assay
Lack of Process Controls
Incorrect Product Formulation
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.